Henrik Vissing

3.4k total citations · 2 hit papers
48 papers, 2.8k citations indexed

About

Henrik Vissing is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Henrik Vissing has authored 48 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 24 papers in Genetics and 10 papers in Surgery. Recurrent topics in Henrik Vissing's work include Connective tissue disorders research (9 papers), Pancreatic function and diabetes (9 papers) and Diabetes and associated disorders (5 papers). Henrik Vissing is often cited by papers focused on Connective tissue disorders research (9 papers), Pancreatic function and diabetes (9 papers) and Diabetes and associated disorders (5 papers). Henrik Vissing collaborates with scholars based in United States, Denmark and United Kingdom. Henrik Vissing's co-authors include Niels Tommerup, Wolfram Meyer, Hans‐Jürgen Thiesen, Joshua R. Friedman, Judith Margolin, F. J. Rauscher, Francesco Ramirez, Jim Holloway, David Heard and Peder Lisby Nørby and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Henrik Vissing

46 papers receiving 2.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression

1998 569 citations David E. Jensen, Sandra T. Marquis et al. Oncogene profile →
Krüppel-associated boxes are potent transcriptional repression domains.

1994 516 citations Wolfram Meyer, Henrik Vissing et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henrik Vissing United States	25	2.0k	906	419	331	219	48	2.8k
Ann Johnsson Sweden	7	1.6k 0.8×	410 0.5×	594 1.4×	341 1.0×	203 0.9×	7	2.6k
Gary B. Silberstein United States	24	1.6k 0.8×	886 1.0×	1.4k 3.2×	256 0.8×	160 0.7×	29	2.7k
Michael J. Getz United States	31	1.8k 0.9×	409 0.5×	348 0.8×	288 0.9×	234 1.1×	55	2.5k
R V Lebo United States	23	1.1k 0.5×	415 0.5×	204 0.5×	381 1.2×	294 1.3×	40	2.2k
L Nelles Belgium	29	1.8k 0.9×	279 0.3×	600 1.4×	992 3.0×	181 0.8×	68	3.2k
Mario N. Lioubin United States	23	2.1k 1.0×	299 0.3×	879 2.1×	314 0.9×	322 1.5×	29	3.1k
Bernd Hinzmann Germany	24	1.7k 0.9×	417 0.5×	808 1.9×	958 2.9×	220 1.0×	47	3.0k
Reiko Sasada Japan	26	1.6k 0.8×	421 0.5×	516 1.2×	288 0.9×	342 1.6×	50	2.9k
N.C. Popescu United States	27	1.8k 0.9×	537 0.6×	1.3k 3.1×	466 1.4×	143 0.7×	48	3.0k
J T Holt United States	16	1.7k 0.9×	587 0.6×	755 1.8×	282 0.9×	103 0.5×	32	2.5k

Countries citing papers authored by Henrik Vissing

Since Specialization

Citations

This map shows the geographic impact of Henrik Vissing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Vissing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Vissing more than expected).

Fields of papers citing papers by Henrik Vissing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Vissing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Vissing. The network helps show where Henrik Vissing may publish in the future.

Co-authorship network of co-authors of Henrik Vissing

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Vissing. A scholar is included among the top collaborators of Henrik Vissing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Vissing. Henrik Vissing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johannesen, Jesper, Allan E. Karlsen, Allan Jensen, et al.. (2004). Is Mortalin a Candidate Gene for T1DM ?. Autoimmunity. 37(6-7). 423–430. 7 indexed citations

Vissing, Henrik, Birgitte Holst, Søren A. Urhammer, et al.. (2004). Studies of relationships between variation of the human G protein‐coupled receptor 40 Gene and Type 2 diabetes and insulin release. Diabetic Medicine. 22(1). 74–80. 41 indexed citations

Vissing, Henrik, et al.. (2000). Assignment<footref rid="foot01"><sup>1</sup></footref> of the NR2E3 gene to mouse chromosome 9 and to human chromosome 15q22.33→q23. Cytogenetic and Genome Research. 89(3-4). 279–280. 2 indexed citations

Wright, Lisa, A.M. Brzozowski, Roderick E. Hubbard, et al.. (2000). Structure of Fab hGR-2 F6, a competitive antagonist of the glucagon receptor. Acta Crystallographica Section D Biological Crystallography. 56(5). 573–580. 4 indexed citations

Johnstone, Ricky W., et al.. (1998). Ciao 1 Is a Novel WD40 Protein That Interacts with the Tumor Suppressor Protein WT1. Journal of Biological Chemistry. 273(18). 10880–10887. 56 indexed citations

Madsen, Bente Kühn, Birgitte Georg, Henrik Vissing, & Jan Fahrenkrug. (1998). Retinoic acid down-regulates the expression of the vasoactive intestinal polypeptide receptor type-1 in human breast carcinoma cell lines.. PubMed. 58(21). 4845–50. 17 indexed citations

Jensen, David E., Sandra T. Marquis, Heather Perry Gardner, et al.. (1998). BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene. 16(9). 1097–1112. 569 indexed citations breakdown →

Johnstone, Ricky W., Niels Tommerup, Claus Hansen, Henrik Vissing, & Yang Shi. (1998). Mapping of the Human PAWR (par-4) Gene to Chromosome 12q21. Genomics. 53(2). 241–243. 36 indexed citations

Røder, Michael, Henrik Vissing, & Michael A. Nauck. (1996). Hyperproinsulinemia in a three-generation Caucasian family due to mutant proinsulin (Arg65-His) not associated with imparied glucose tolerance: the contribution of mutant proinsulin to insulin bioactivity.. The Journal of Clinical Endocrinology & Metabolism. 81(4). 1634–1640. 13 indexed citations

10.

Tommerup, Niels & Henrik Vissing. (1995). Isolation and Fine Mapping of 16 Novel Human Zinc Finger-Encoding cDNAs Identify Putative Candidate Genes for Developmental and Malignant Disorders. Genomics. 27(2). 259–264. 114 indexed citations

11.

Vissing, Henrik, et al.. (1995). Repression of transcriptional activity by heterologous KRAB domains present in zinc finger proteins. FEBS Letters. 369(2-3). 153–157. 135 indexed citations

12.

Vissing, Henrik, et al.. (1994). Localization of the Human Gene for Advanced Glycosylation End Product-Specific Receptor (AGER) to Chromosome 6p21.3. Genomics. 24(3). 606–608. 26 indexed citations

13.

Tommerup, Niels, Esper Boel, Sarah Baxendale, et al.. (1993). A zinc-finger gene ZNF141 mapping at 4p16.3/D4S90 is a candidate gene for the Wolf-Hirschhorn (4p-) syndrome. Human Molecular Genetics. 2(10). 1571–1575. 42 indexed citations

14.

Vissing, Henrik, et al.. (1990). A glycine to serine polymorphism in the C-propeptide of the human type II procollagen. Nucleic Acids Research. 18(11). 3431–3431. 9 indexed citations

15.

Ramirez, Francesco, Sharon Boast, Marina D’Alessio, et al.. (1990). Fibrillar Collagen Genes. Annals of the New York Academy of Sciences. 580(1). 74–80. 10 indexed citations

16.

Tuinen, Peter van, et al.. (1988). . Nucleic Acids Research. 16(13). 6250–6250. 2 indexed citations

17.

Litt, M., et al.. (1988). Cosmid 128 defines three RFLPs on chromosome 17q23-qter. [HGM9 no. D17S77]. Nucleic Acids Research. 16(13). 6251–6251. 5 indexed citations

18.

vanTuinen, Peter, et al.. (1987). An anonymous single-copy clone, pC63, from chromosome 17q23-qter identifies a frequent RFLP [HGM9 No. D17S21]. Nucleic Acids Research. 15(21). 9096–9096. 9 indexed citations

19.

Vissing, Henrik, et al.. (1987). A hypervariable RFLP on chromosome 17pl3 is defined by an arbitrary single copy probe pl44-D6 [HGM9 No. D17S34]. Nucleic Acids Research. 15(24). 10605–10605. 57 indexed citations

20.

Vissing, Henrik, George K. Papadopoulos, & Åke Lernmark. (1986). Monoclonal Antibodies against Pancreatic Islet‐Cell‐Surface Antigens Selected by Flow Cytofluorometry. Scandinavian Journal of Immunology. 23(4). 425–433. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact